GH Research PLC Earnings

The next earnings date for GH Research PLC has not yet been scheduled.

Analyst Estimates of GH Research PLC Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

GH Research PLC Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/14/2026	Before Market	$-0.31	-9.81%
03/05/2026	Before Market	$-0.23	16.49%
11/06/2025	Before Market	$-0.23	4.72%
08/07/2025	Before Market	$-0.15	31.19%
05/08/2025	Before Market	$-0.19	52.24%
02/27/2025	Before Market	$-0.17	31.51%
11/14/2024	Before Market	$-0.23	10.33%
09/03/2024	Before Market	$-0.20	14.75%
05/03/2024	Before Market	$-0.15	33.39%
02/29/2024	Before Market	$-0.21	-1.30%
11/09/2023	After Market	$-0.11	45.87%
08/23/2023	Before Market	$-0.15	41.97%
05/11/2023	Before Market	$-0.21	4.68%
03/02/2023	Before Market	$-0.32	-85.79%
11/10/2022	Before Market	$-0.01	95.17%
08/23/2022	Before Market	$0.01	103.39%
05/18/2022	Before Market	$-0.11	33.97%
03/28/2022	Before Market	$-0.09	51.82%
12/06/2021	Before Market	$-0.04	65.69%
09/23/2021	After Market	$-0.05	38.73%

More About GH Research PLC

Website

https://www.ghres.com

Country

USA

Full Time Employees

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

“GH Research PLC Earnings” Can Refer to the GH Research PLC Earnings Date

Some people say “GH Research PLC earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my GH Research PLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning GH Research PLC Stock on the Earnings Date

If you own GH Research PLC stock (GHRS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for GH Research PLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading GH Research PLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More GH Research PLC Earnings

You can contact us any time if you would like to ask questions about GH Research PLC earnings or anything else related to the stock market.